Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood cancer
CRO
Roche's Flatiron Health debuts 6 new blood cancer data sets
The new data come from 505,000 records from patients with multiple myeloma and five kinds of B-cell lymphoma.
Darren Incorvaia
Oct 29, 2025 9:00am
Ignota buys Kronos' pipeline to rescue shelved programs
Oct 6, 2025 5:45am
Gilead's Kite erodes $2.3B Shoreline cell therapy deal
Sep 3, 2025 3:18pm
BeOne asset hits primary endpoint, tees up blood cancer filings
Aug 29, 2025 9:50am
J&J lymphoma CAR-T hits 100% ORR in 10 patients
Jun 13, 2025 1:22pm
ASCO: Kite's CAR-T flies high in phase 1 B-cell lymphoma study
May 31, 2025 7:00pm